Drug General Information (ID: D1443)
  Drug Name
Samarium (153Sm) lexidronam
  Drug Type Small molecule
  Drug Synonymous
7440-19-9; Samarium; Sm; samario; samarium atom; UNII-42OD65L39F; 62Sm; 42OD65L39F; MFCD00011233; MFCD00151299; Samarium, elemental; Samariumpowder; Samarium powder; Samarium ingot; HSDB 7863; Samarium Nanofoil; EINECS 231-128-7; Samarium foil, 3N; Samarium ingot, 3N; Samarium Nanoparticles; Samarium pieces, 3N; Samarium chunks,99.9%; Samarium powder,99.9%; Samarium powder, -40 mesh; Ultra Thin Samarium Nanofoil; Samarium Nanoparticle Dispersion; DTXSID4064688; Samarium Metal Organic Framework; Samarium Metal-Organic Framework; 1,2-Diacylglycerol-LD-SM-pool; CHEBI:33374; Samarium pieces, sublimed dendritic; AMY22263; 8996AF; AKOS024438061; DB12403; Samarium rod, 12.7mm (0.5in) dia; Samarium foil, 1.0mm (0.04in) thick; Samarium rod, 6.35mm (0.25in) dia; BP-21451; Samarium foil, 0.1mm (0.004in) thick; Samarium foil, 0.25mm (0.01in) thick; Samarium foil, 0.75mm (0.03in) thick; Samarium pieces, 12mm (0.47in) & down; Samarium foil, 0.62mm (0.024in) thick; Samarium powder (99.9% REO) 325 mesh; Q1819; Samarium foil, 0.025mm (0.001in) thick; Samarium foil, 0.127mm (0.005in) thick; D78246; Lanthanum Vanadium (LaVO3) Sputtering Targets; Samarium ingot/button, ca. 50.8mm (2.0in) dia; Samarium, chips, 99.9% trace rare earth metals basis; Samarium, ingot, 99.9% trace rare earth metals basis; Samarium, rod, 100mm, diameter 6.35mm, cast, 99%; Samarium, rod, 50mm, diameter 6.35mm, cast, 99%; Samarium, -40 mesh, 99% trace rare earth metals basis; Samarium, AAS standard solution, Specpure?, Sm 1000?g/ml; Samarium, foil, 25x25mm, thickness 0.1mm, as rolled, 99%; Samarium, foil, 25x25mm, thickness 0.25mm, as rolled, 99%; Samarium, foil, 50x50mm, thickness 0.1mm, as rolled, 99%; Samarium, foil, 50x50mm, thickness 0.25mm, as rolled, 99%; Samarium, plasma standard solution, Specpure?, Sm 1000?g/ml; Samarium, foil, thickness 0.5 mm, 15 mm diameter, purity 99%; Samarium, foil, thickness 0.7 mm, 15 mm diameter, purity 99%; Samarium, lump, 25 mm max. lump size, weight 10 g, purity 99.9%; Samarium, lump, 25 mm max. lump size, weight 20 g, purity 99.9%; Samarium, lump, 25 mm max. lump size, weight 50 g, purity 99.9%; Samarium, plasma standard solution, Specpure?, Sm 10,000?g/ml; Samarium hydride, 99.9%, - 325 mesh SmH2 -3, Hydrogen level may vary; Samarium, foil, thickness 1 mm, 99.9% trace rare earth metals basis; AA Grade Samarium 1,000 mg/L inverted exclamation markA 2% in 2% HNO3, 100 ml; Samarium, foil, not light tested, 25x25mm, thickness 0.005mm, as rolled, 99%; Samarium, foil, not light tested, 25x25mm, thickness 0.025mm, as rolled, 99%; Samarium, foil, not light tested, 50x50mm, thickness 0.025mm, as rolled, 99%; Samarium, powder, 500 max. part. size (micron), weight 10 g, purity 99.9%; Samarium, powder, 500 max. part. size (micron), weight 20 g, purity 99.9%; Samarium, powder, max. particle size 500 micron, weight 50 g, purity 99.9%
    Click to Show/Hide
  Therapeutic Class Therapeutic Radiopharmaceuticals
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula Sm
  InChI InChI=1S/Sm
  InChIKey KZUNJOHGWZRPMI-UHFFFAOYSA-N
  Canonical SMILES [Sm]
  External Link
Pubchem ID 23951

Drug-Drug Interaction Network
  Sunburst Graph
AM003  Affected organization distribution
AM006  Pharmacodynamic additive effects
BM014  Interference of cell/tissue uptake
BM043  Additive immunosuppressive effects
BM044  Additive myelosuppressive effects
BM063  Increased risk of hypocalcemia
  Relation Graph
 Full list of drugs interacting with Samarium (153Sm) lexidronam
      Affected organization distribution
   Interference of cell/tissue uptake Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0623
 
Etidronic acid
 
C2H8O7P2
 
3305 
Moderate    Inter Info   
[6], [7], [8]
      Pharmacodynamic additive effects
   Additive immunosuppressive effects Drug Num:  2
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0348
 
Cladribine
 
C10H12ClN5O3
 
20279 
Major    Inter Info   
[2], [3]
D1162
 
Ocrelizumab
 
NA
 
NA
Moderate    Inter Info   
[14]
   Additive myelosuppressive effects Drug Num:  144
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0030
 
Aldesleukin
 
NA
 
NA
Major    Inter Info   
[1]
D0033
 
Alemtuzumab
 
NA
 
NA
Major    Inter Info   
[1]
D0048
 
Altretamine
 
C9H18N6
 
2123 
Major    Inter Info   
[1]
D0134
 
Azacitidine
 
C8H12N4O5
 
9444 
Major    Inter Info   
[1]
D0136
 
Azathioprine
 
C9H7N7O2S
 
2265 
Major    Inter Info   
[1]
D0153
 
Belinostat
 
C15H14N2O4S
 
6918638 
Major    Inter Info   
[1]
D0177
 
Bevacizumab
 
NA
 
NA
Major    Inter Info   
[1]
D0178
 
Bexarotene
 
C24H28O2
 
82146 
Major    Inter Info   
[1]
D0190
 
Bleomycin
 
C55H84N17O21S3+
 
5360373 
Major    Inter Info   
[1]
D0193
 
Bortezomib
 
C19H25BN4O4
 
387447 
Major    Inter Info   
[1]
D0223
 
Busulfan
 
C6H14O6S2
 
2478 
Major    Inter Info   
[1]
D0260
 
Carboplatin
 
C6H12N2O4Pt
 
426756 
Major    Inter Info   
[1]
D0264
 
Carmustine
 
C5H9Cl2N3O2
 
2578 
Major    Inter Info   
[1]
D0312
 
Chlorambucil
 
C14H19Cl2NO2
 
2708 
Major    Inter Info   
[1]
D0344
 
Cisplatin
 
Cl2H6N2Pt
 
5702198 
Major    Inter Info   
[1]
D0357
 
Clofarabine
 
C10H11ClFN5O3
 
119182 
Major    Inter Info   
[1]
D0370
 
Clozapine
 
C18H19ClN4
 
135398737 
Major    Inter Info   
[2], [4], [5]
D0376
 
Cobimetinib
 
C21H21F3IN3O2
 
16222096 
Major    Inter Info   
[1]
D0400
 
Cyclophosphamide
 
C7H15Cl2N2O2P
 
2907 
Major    Inter Info   
[1]
D0404
 
Cytarabine
 
C9H13N3O5
 
6253 
Major    Inter Info   
[1]
D0407
 
Dacarbazine
 
C6H10N6O
 
135398738 
Major    Inter Info   
[1]
D0410
 
Dactinomycin
 
C62H86N12O16
 
457193 
Major    Inter Info   
[1]
D0428
 
Dasatinib
 
C22H26ClN7O2S
 
3062316 
Major    Inter Info   
[1]
D0429
 
Daunorubicin
 
C27H29NO10
 
30323 
Major    Inter Info   
[1]
D0430
 
Daunorubicin (liposomal)
 
C27H29NO10
 
30323 
Major    Inter Info   
[1]
D0431
 
Decitabine
 
C8H12N4O4
 
451668 
Major    Inter Info   
[1]
D0511
 
Docetaxel
 
C43H53NO14
 
148124 
Major    Inter Info   
[1]
D0528
 
Doxorubicin
 
C27H29NO11
 
31703 
Major    Inter Info   
[1]
D0529
 
Doxorubicin (liposomal)
 
C27H29NO11
 
31703 
Major    Inter Info   
[1]
D0584
 
Epirubicin
 
C27H29NO11
 
41867 
Major    Inter Info   
[1]
D0627
 
Etoposide
 
C29H32O13
 
36462 
Major    Inter Info   
[1]
D0666
 
Floxuridine
 
C9H11FN2O5
 
5790 
Major    Inter Info   
[1]
D0669
 
Fludarabine
 
C10H12FN5O4
 
657237 
Major    Inter Info   
[1]
D0675
 
Fluorouracil
 
C4H3FN2O2
 
3385 
Major    Inter Info   
[1]
D0714
 
Gemcitabine
 
C9H11F2N3O4
 
60750 
Major    Inter Info   
[1]
D0717
 
Gemtuzumab ozogamicin
 
NA
 
NA
Major    Inter Info   
[1]
D0780
 
Hydroxyurea
 
CH4N2O2
 
3657 
Major    Inter Info   
[1]
D0784
 
Ibritumomab tiuxetan
 
NA
 
NA
Major    Inter Info   
[1]
D0788
 
Idarubicin
 
C26H27NO9
 
42890 
Major    Inter Info   
[1]
D0793
 
Imatinib
 
C29H31N7O
 
5291 
Major    Inter Info   
[1]
D0821
 
Interferon alfa-2a, Recombinant
 
NA
 
NA
Major    Inter Info   
[1]
D0822
 
Interferon alfa-2b
 
C16H17Cl3I2N3NaO5S
 
71306834 
Major    Inter Info   
[1]
D0824
 
Interferon alfa-n1
 
NA
 
NA
Major    Inter Info   
[1]
D0823
 
Interferon alfacon-1
 
NA
 
NA
Major    Inter Info   
[1]
D0828
 
Interferon gamma-1b
 
NA
 
NA
Major    Inter Info   
[1]
D0845
 
Irinotecan
 
C33H38N4O6
 
60838 
Major    Inter Info   
[1]
D0846
 
Irinotecan (liposomal)
 
C33H38N4O6
 
60838 
Major    Inter Info   
[1]
D0873
 
Ixabepilone
 
C27H42N2O5S
 
6445540 
Major    Inter Info   
[1]
D0902
 
Lenalidomide
 
C13H13N3O3
 
216326 
Major    Inter Info   
[1]
D0945
 
Lomustine
 
C9H16ClN3O2
 
3950 
Major    Inter Info   
[1]
D0996
 
Melphalan
 
C13H18Cl2N2O2
 
460612 
Major    Inter Info   
[1]
D1007
 
Mercaptopurine
 
C5H4N4S
 
667490 
Major    Inter Info   
[1]
D1025
 
Methotrexate
 
C20H22N8O5
 
126941 
Major    Inter Info   
[1]
D1077
 
Mitomycin
 
C15H18N4O5
 
5746 
Major    Inter Info   
[1]
D1079
 
Mitoxantrone
 
C22H28N4O6
 
4212 
Major    Inter Info   
[1]
D1118
 
Nelarabine
 
C11H15N5O5
 
3011155 
Major    Inter Info   
[1]
D1136
 
Nilotinib
 
C28H22F3N7O
 
644241 
Major    Inter Info   
[1]
D1174
 
Omacetaxine mepesuccinate
 
C29H39NO9
 
285033 
Major    Inter Info   
[1]
D1193
 
Oxaliplatin
 
C8H14N2O4Pt
 
9887053 
Major    Inter Info   
[1]
D1213
 
Paclitaxel (protein-bound)
 
C47H51NO14
 
36314 
Major    Inter Info   
[1]
D1237
 
Peginterferon alfa-2a
 
NA
 
NA
Major    Inter Info   
[1]
D1238
 
Peginterferon alfa-2b
 
NA
 
NA
Major    Inter Info   
[1]
D1241
 
Pemetrexed
 
C20H21N5O6
 
135410875 
Major    Inter Info   
[1]
D1250
 
Pentostatin
 
C11H16N4O4
 
439693 
Major    Inter Info   
[1]
D1345
 
Procarbazine
 
C12H19N3O
 
4915 
Major    Inter Info   
[1]
D1416
 
Rituximab
 
NA
 
NA
Major    Inter Info   
[1]
D0006
 
Abemaciclib
 
C27H32F2N8
 
46220502 
Major    Inter Info   
[1]
D0027
 
Aflibercept
 
NA
 
NA
Major    Inter Info   
[1]
D0129
 
Avapritinib
 
C26H27FN10
 
118023034 
Major    Inter Info   
[1]
D0132
 
Axicabtagene ciloleucel
 
NA
 
NA
Major    Inter Info   
[1]
D0146
 
Baricitinib
 
C16H17N7O2S
 
44205240 
Major    Inter Info   
[1]
D0150
 
Belantamab mafodotin
 
NA
 
NA
Major    Inter Info   
[1]
D0157
 
Bendamustine
 
C16H21Cl2N3O2
 
65628 
Major    Inter Info   
[1]
D0191
 
Blinatumomab
 
NA
 
NA
Major    Inter Info   
[1]
D0195
 
Bosutinib
 
C26H29Cl2N5O3
 
5328940 
Major    Inter Info   
[1]
D0199
 
Brentuximab vedotin
 
NA
 
NA
Major    Inter Info   
[1]
D0203
 
Brexucabtagene autoleucel
 
NA
 
NA
Major    Inter Info   
[1]
D0227
 
Cabazitaxel
 
C45H57NO14
 
9854073 
Major    Inter Info   
[1]
D0261
 
Carfilzomib
 
C40H57N5O7
 
11556711 
Major    Inter Info   
[1]
D0389
 
Copanlisib
 
C23H28N8O4
 
135565596 
Major    Inter Info   
[1]
D0422
 
Daratumumab
 
NA
 
NA
Major    Inter Info   
[1]
D0501
 
Dinutuximab
 
NA
 
NA
Major    Inter Info   
[1]
D0543
 
Duvelisib
 
C22H17ClN6O
 
50905713 
Major    Inter Info   
[1]
D0560
 
Elotuzumab
 
NA
 
NA
Major    Inter Info   
[1]
D0571
 
Enfortumab vedotin
 
NA
 
NA
Major    Inter Info   
[1]
D0594
 
Eribulin
 
C40H59NO11
 
11354606 
Major    Inter Info   
[1]
D0785
 
Ibrutinib
 
C25H24N6O2
 
24821094 
Major    Inter Info   
[1]
D0789
 
Idelalisib
 
C22H18FN7O
 
11625818 
Major    Inter Info   
[1]
D0806
 
Inotuzumab ozogamicin
 
NA
 
NA
Major    Inter Info   
[1]
D0829
 
Iobenguane (I-131)
 
C8H10IN3
 
60860 
Major    Inter Info   
[1]
D0851
 
Isatuximab
 
NA
 
NA
Major    Inter Info   
[1]
D0874
 
Ixazomib
 
C14H19BCl2N2O4
 
25183872 
Major    Inter Info   
[1]
D0939
 
Lisocabtagene maraleucel
 
NA
 
NA
Major    Inter Info   
[1]
D0962
 
Lurbinectedin
 
C41H44N4O10S
 
57327016 
Major    Inter Info   
[1]
D0964
 
Lutetium Lu 177 dotatate
 
C65H87LuN14O19S2
 
76966897 
Major    Inter Info   
[1]
D1062
 
Midostaurin
 
C35H30N4O4
 
9829523 
Major    Inter Info   
[1]
D1083
 
Mogamulizumab
 
NA
 
NA
Major    Inter Info   
[1]
D1113
 
Naxitamab
 
NA
 
NA
Major    Inter Info   
[1]
D1140
 
Niraparib
 
C19H20N4O
 
24958200 
Major    Inter Info   
[1]
D1161
 
Obinutuzumab
 
NA
 
NA
Major    Inter Info   
[1]
D1164
 
Ofatumumab
 
NA
 
NA
Major    Inter Info   
[1]
D1167
 
Olaparib
 
C24H23FN4O3
 
23725625 
Major    Inter Info   
[1]
D1190
 
Osimertinib
 
C28H33N7O2
 
71496458 
Major    Inter Info   
[1]
D1214
 
Palbociclib
 
C24H29N7O2
 
5330286 
Major    Inter Info   
[1]
D1221
 
Panobinostat
 
C21H23N3O2
 
6918837 
Major    Inter Info   
[1]
D1232
 
Pazopanib
 
C21H23N7O2S
 
10113978 
Major    Inter Info   
[1]
D1305
 
Plicamycin
 
C52H76O24
 
163659 
Major    Inter Info   
[1]
D1306
 
Polatuzumab vedotin
 
NA
 
NA
Major    Inter Info   
[1]
D1312
 
Pomalidomide
 
C13H11N3O4
 
134780 
Major    Inter Info   
[1]
D1313
 
Ponatinib
 
C29H27F3N6O
 
24826799 
Major    Inter Info   
[1]
D1323
 
Pralatrexate
 
C23H23N7O5
 
148121 
Major    Inter Info   
[1]
D1398
 
Ribociclib
 
C23H30N8O
 
44631912 
Major    Inter Info   
[1]
D1424
 
Romidepsin
 
C24H36N4O6S2
 
5352062 
Major    Inter Info   
[1]
D1432
 
Rucaparib
 
C19H18FN3O
 
9931954 
Major    Inter Info   
[1]
D1448
 
Satralizumab
 
NA
 
NA
Major    Inter Info   
[1]
D1458
 
Selinexor
 
C17H11F6N7O
 
71481097 
Major    Inter Info   
[1]
D1529
 
Tafasitamab
 
NA
 
NA
Major    Inter Info   
[1]
D1532
 
Talazoparib
 
C19H14F2N6O
 
135565082 
Major    Inter Info   
[1]
D1594
 
Tisagenlecleucel
 
NA
 
NA
Major    Inter Info   
[1]
D1600
 
Tofacitinib
 
C16H20N6O
 
9926791 
Major    Inter Info   
[1]
D1622
 
Trastuzumab deruxtecan
 
NA
 
NA
Major    Inter Info   
[1]
D1666
 
Upadacitinib
 
C17H19F3N6O
 
58557659 
Major    Inter Info   
[1]
D1688
 
Venetoclax
 
C45H50ClN7O7S
 
49846579 
Major    Inter Info   
[1]
D1718
 
Zanubrutinib
 
C27H29N5O3
 
135565884 
Major    Inter Info   
[1]
D1508
 
Streptozocin
 
C8H15N3O7
 
29327 
Major    Inter Info   
[1]
D1548
 
Temozolomide
 
C6H6N6O2
 
5394 
Major    Inter Info   
[1]
D1551
 
Teniposide
 
C32H32O13S
 
452548 
Major    Inter Info   
[1]
D1569
 
Thalidomide
 
C13H10N2O4
 
5426 
Major    Inter Info   
[1]
D1575
 
Thiotepa
 
C6H12N3PS
 
5453 
Major    Inter Info   
[1]
D1589
 
Tioguanine
 
C5H5N5S
 
2723601 
Major    Inter Info   
[1]
D1610
 
Topotecan
 
C23H23N3O5
 
60700 
Major    Inter Info   
[1]
D1613
 
Tositumomab
 
NA
 
NA
Major    Inter Info   
[1]
D1614
 
Tositumomab (I-131)
 
NA
 
NA
Major    Inter Info   
[1]
D1615
 
Trabectedin
 
C39H43N3O11S
 
108150 
Major    Inter Info   
[1]
D1621
 
Trastuzumab
 
NA
 
NA
Major    Inter Info   
[1]
D1639
 
Trifluridine
 
C10H11F3N2O5
 
6256 
Major    Inter Info   
[1]
D1646
 
Trimetrexate
 
C19H23N5O3
 
5583 
Major    Inter Info   
[1]
D1667
 
Uracil mustard
 
C8H11Cl2N3O2
 
6194 
Major    Inter Info   
[1]
D1697
 
Vinblastine
 
C46H58N4O9
 
13342 
Major    Inter Info   
[1]
D1698
 
Vincristine
 
C46H56N4O10
 
5978 
Major    Inter Info   
[1]
D1699
 
Vincristine (liposome)
 
C46H56N4O10
 
5978 
Major    Inter Info   
[1]
D1700
 
Vinorelbine
 
C45H54N4O8
 
5311497 
Major    Inter Info   
[1]
D0710
 
Ganciclovir
 
C9H13N5O4
 
135398740 
Moderate    Inter Info   
[12], [2], [13]
D1676
 
Valganciclovir
 
C14H22N6O5
 
135413535 
Moderate    Inter Info   
[12], [2], [13]
   Increased risk of hypocalcemia Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0694
 
Foscarnet
 
CH3O5P
 
3415 
Moderate    Inter Info   
[9], [10], [11]
References
1 Product Information. Quadramet (samarium sm 153 lexidronam) Berlex Laboratories, Richmond, CA.
2 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3 Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
4 Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
5 Canadian Pharmacists Association "e-CPS."
6 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
7 Multum Information Services, Inc. Expert Review Panel.
8 Product Information. Didronel Tablets (etidronate). Procter and Gamble Pharmaceuticals, Cincinnati, OH.
9 Foscarnet: a review. Drugs 41 (1991): 106-29. [PMID: 1706982]
10 Product Information. Foscavir (foscarnet). Astra USA, Westborough, MA.
11 Youle M, Clarbour J, Gazzard B, Chanas A "Severe hypocalcemia in AIDS patients treated with foscarnet and pentamidine." Lancet 1 (1988): 1455-6. [PMID: 2898602]
12 Cerner Multum, Inc. "Australian Product Information.".
13 Product Information. Valcyte (valganciclovir) Roche Laboratories, Nutley, NJ.
14 Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.